These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28279690)

  • 1. [Early clinical trials in paediatric oncology in Spain: a nationwide perspective].
    Bautista F; Gallego S; Cañete A; Mora J; Díaz de Heredia C; Cruz O; Fernández JM; Rives S; Berlanga P; Hladun R; Juan Ribelles A; Madero L; Ramírez M; Fernández Delgado R; Pérez-Martínez A; Mata C; Llort A; Martín Broto J; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L; ;
    An Pediatr (Barc); 2017 Sep; 87(3):155-163. PubMed ID: 28279690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
    Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
    Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
    Rubio-San-Simón A; Hladun Alvaro R; Juan Ribelles A; Castañeda Heredia A; Guerra-García P; Verdú-Amorós J; Andrés M; Cañete A; Rives S; Pérez-Martínez A; Mora J; Patiño-García A; Lassaleta A; Llort A; Ramírez M; Mata C; Gallego S; Martín-Broto J; Cruz O; Morales La Madrid A; Solano P; Martínez Romera I; Fernández-Teijeiro A; Bautista F; Moreno L
    Clin Transl Oncol; 2021 Dec; 23(12):2489-2496. PubMed ID: 34076861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain.
    Bautista F; Cañete A; Ramírez-Villar GL; Fernández JM; Fuster JL; Diaz de Heredia C; Astigarraga I; García-Ariza M; Rives S; Dapena JL; Márquez C; Molinés A; Bermúdez MDM; Gallego S; Andrés MDM; Verdu-Amoros J; Hernández C; López M; Catalá A; Lassaletta Á; Cruz O; Ramírez M; Lendínez F; Carboné A; Gomez Sirvent J; Tallón M; Acha T; Moreno L; Fernández-Teijeiro A;
    Clin Transl Oncol; 2019 Dec; 21(12):1763-1770. PubMed ID: 31598904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
    Rubio-San-Simón A; Verdú-Amorós J; Hladun R; Juan-Ribelles A; Molero M; Guerra-García P; Pérez-Martínez A; Castañeda A; Cañete A; de Rojas T; Moreno L; Bautista F
    Clin Transl Oncol; 2021 Jan; 23(1):183-189. PubMed ID: 32472454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium.
    Bautista F; Moreno L; Marshall L; Pearson ADJ; Geoerger B; Paoletti X
    Eur J Cancer; 2017 Nov; 86():275-284. PubMed ID: 29055843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of mechanism of action biology-driven early drug development for children with cancer.
    Pearson AD; Herold R; Rousseau R; Copland C; Bradley-Garelik B; Binner D; Capdeville R; Caron H; Carleer J; Chesler L; Geoerger B; Kearns P; Marshall LV; Pfister SM; Schleiermacher G; Skolnik J; Spadoni C; Sterba J; van den Berg H; Uttenreuther-Fischer M; Witt O; Norga K; Vassal G;
    Eur J Cancer; 2016 Jul; 62():124-31. PubMed ID: 27258969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.
    Juan-Ribelles A; Bautista F; Cañete A; Rubio-San-Simón A; Alonso-Saladrigues A; Hladun R; Rives S; Dapena JL; Fernández JM; Lassaletta Á; Cruz O; Ramírez-Villar G; Fuster JL; de Heredia CD; García-Ariza M; Quiroga E; Del Mar Andrés M; Verdú-Amorós J; Molinés A; Herrero B; López M; Márquez C; Toboso M; Lendínez F; Sirvent JG; Tallón M; Rodríguez G; Acha T; Moreno L; Fernández-Teijeiro A;
    Clin Transl Oncol; 2024 Sep; 26(9):2351-2359. PubMed ID: 38600340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.
    Rubio-San-Simón A; André N; Cefalo MG; Aerts I; Castañeda A; Benezech S; Makin G; van Eijkelenburg N; Nysom K; Marshall L; Gambart M; Hladun R; Rossig C; Bergamaschi L; Fagioli F; Carpenter B; Ducassou S; Owens C; Øra I; Ribelles AJ; De Wilde B; Guerra-García P; Strullu M; Rizzari C; Ek T; Hettmer S; Gerber NU; Rawlings C; Diezi M; Palmu S; Ruggiero A; Verdú J; de Rojas T; Vassal G; Geoerger B; Moreno L; Bautista F
    Eur J Cancer; 2020 Dec; 141():82-91. PubMed ID: 33129040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.
    Zwaan CM; Kearns P; Caron H; Verschuur A; Riccardi R; Boos J; Doz F; Geoerger B; Morland B; Vassal G;
    Cancer Treat Rev; 2010 Jun; 36(4):328-34. PubMed ID: 20231057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
    Gargallo P; Bautista F; Juan-Ribelles A; Izquierdo E; Soriano A; de Rojas T; Escudero A; Lavarino C; Solano P; Hladun R; Rubio-San-Simón A; Martínez-Romera I; Calabria I; Olaciregui NG; Castañeda-Heredia A; de Álava E; Pérez-Martínez A; Astigarraga I; Patiño-García A; Alonso J; Fernández-Teijeiro A; Cañete A; Moreno L
    Clin Transl Oncol; 2022 May; 24(5):809-815. PubMed ID: 35152364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endpoints in paediatric oncology.
    Paolucci P; Cioni V; Bigi E; Lucaccioni L; Cano C
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():33-40. PubMed ID: 21085937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.
    Carceller F; Bautista FJ; Jiménez I; Hladun-Álvaro R; Giraud C; Bergamaschi L; Dandapani M; Aerts I; Doz F; Frappaz D; Casanova M; Morland B; Hargrave DR; Marshall LV; Vassal G; Pearson AD; Geoerger B; Moreno L
    Eur J Cancer; 2016 Nov; 67():130-140. PubMed ID: 27662616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.
    Moreno L; Pearson ADJ; Paoletti X; Jimenez I; Geoerger B; Kearns PR; Zwaan CM; Doz F; Baruchel A; Vormoor J; Casanova M; Pfister SM; Morland B; Vassal G;
    Nat Rev Clin Oncol; 2017 Aug; 14(8):497-507. PubMed ID: 28508875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.
    Bautista F; Verdú-Amorós J; Geoerger B; Rubio-San-Simón A; Paoletti X; Zwaan CM; Casanova M; Marshall LV; Carceller F; Doz F; Lecinse C; Vassal G; Pearson ADJ; Kearns P; Moreno L;
    J Clin Oncol; 2024 Jul; 42(21):2516-2526. PubMed ID: 38743911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.